Predicting the effects of long-term medical treatment in acromegaly. At what cost? For what benefits?

被引:8
作者
Chanson, P [1 ]
机构
[1] UNIV PARIS 11,LE KREMLIN BICETR,FRANCE
关键词
D O I
10.1530/eje.0.1360359
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:359 / 361
页数:3
相关论文
共 18 条
  • [11] THERAPY OF ACROMEGALY WITH SANDOSTATIN - THE PREDICTIVE VALUE OF AN ACUTE TEST, THE VALUE OF SERUM SOMATOMEDIN-C MEASUREMENTS IN DOSE ADJUSTMENT AND THE DEFINITION OF A BIOCHEMICAL CURE
    LAMBERTS, SWJ
    UITTERLINDEN, P
    SCHUIJFF, PC
    KLIJN, JGM
    [J]. CLINICAL ENDOCRINOLOGY, 1988, 29 (04) : 411 - 420
  • [12] SLOW-RELEASE LANREOTIDE TREATMENT IN ACROMEGALIC PATIENTS PREVIOUSLY NORMALIZED BY OCTREOTIDE
    MORANGE, I
    DEBOISVILLIERS, F
    CHANSON, P
    LUCAS, B
    DEWAILLY, D
    CATUS, F
    THOMAS, F
    JAQUET, P
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (01) : 145 - 151
  • [13] PREOPERATIVE OCTREOTIDE TREATMENT OF GROWTH HORMONE-SECRETING AND CLINICALLY NONFUNCTIONING PITUITARY MACROADENOMAS - EFFECT ON TUMOR VOLUME AND LACK OF CORRELATION WITH IMMUNOHISTOCHEMISTRY AND SOMATOSTATIN RECEPTOR SCINTIGRAPHY
    PLOCKINGER, U
    REICHEL, M
    FETT, U
    SAEGER, W
    QUABBE, HJ
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (05) : 1416 - 1423
  • [14] Results of somatostatin receptor scintigraphy do not predict pituitary tumor volume- and hormone-response to octreotide therapy and do not correlate with tumor histology
    Plockinger, U
    Bader, M
    Hopfenmuller, W
    Saeger, W
    Quabbe, HJ
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1997, 136 (04) : 369 - 376
  • [15] LONG-TERM EFFECT OF INCREMENTAL DOSES OF THE SOMATOSTATIN ANALOG SMS 201-995 IN 58 ACROMEGALIC PATIENTS
    SASSOLAS, G
    HARRIS, AG
    JAMESDEIDIER, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 71 (02) : 391 - 397
  • [16] PITUITARY IMAGING USING A LABELED SOMATOSTATIN ANALOG IN ACROMEGALY
    UR, E
    MATHER, SJ
    BOMANJI, J
    ELLISON, D
    BRITTON, KE
    GROSSMAN, AB
    WASS, JAH
    BESSER, GM
    [J]. CLINICAL ENDOCRINOLOGY, 1992, 36 (02) : 147 - 150
  • [17] VANCE ML, 1991, ARCH INTERN MED, V151, P1573
  • [18] Treatment options in acromegaly - Benefits and costs
    Weekes, LM
    Ho, KK
    Seale, JP
    [J]. PHARMACOECONOMICS, 1996, 10 (05) : 453 - 459